Skip to main content
Công ty Cổ phần Dược phẩm Cửu Long logo

Công ty Cổ phần Dược phẩm Cửu Long — Investor Relations & Filings

Ticker · DCL ISIN · VN000000DCL1 HSX Manufacturing
Filings indexed 224 across all filing types
Latest filing 2023-03-27 Proxy Solicitation & In…
Country VN Viet Nam
Listing HSX DCL

About Công ty Cổ phần Dược phẩm Cửu Long

http://dcl.com.vn

Cuu Long Pharmaceutical Joint Stock Company (DCL) is a diversified healthcare provider with nearly 50 years of operational history. The company's core activities include the production of pharmaceuticals, medical equipment, and empty hard capsules. DCL is a market leader in empty hard capsules, holding approximately 80% market share. Its pharmaceutical portfolio comprises a range of drugs, chemicals, and medicines. The company serves a broad network of hospitals and medical facilities through an extensive distribution system. DCL is recognized for its commitment to delivering innovative and accessible healthcare products.

Recent filings

Filing Released Lang Actions
DCL: Thông báo tài liệu họp ĐHĐCĐ thường niên năm 2023
Proxy Solicitation & Information Statement Classification · 75% confidence The document is an official 24-hour regulatory disclosure by a Vietnamese listed company to the State Securities Commission and Ho Chi Minh Stock Exchange. It announces and provides the invitation and materials for the Annual General Meeting of shareholders (AGM) and requests shareholder participation via electronic voting. This matches our definition of Proxy Solicitation & Information Statement (PSI), which covers materials sent to shareholders to provide information and request votes for meetings.
2023-03-27 Vietnamese
DCL: Nghị quyết HĐQT về việc thông qua giao dịch với bên có liên quan
Regulatory Filings Classification · 85% confidence The document is a Vietnamese regulatory announcement filed with the State Securities Commission and Ho Chi Minh Stock Exchange disclosing an extraordinary board resolution approving a related-party transaction. It is not an AGM presentation, earnings release, annual or interim report, director change, share issue, or other specific category. It is a mandatory compliance/regulatory disclosure, falling under the general “Regulatory Filings” category.
2023-03-09 Vietnamese
DCL: Nghị quyết HĐQT thông qua việc triển khai phương án phát hành ESOP
Share Issue/Capital Change Classification · 87% confidence The document is a mandatory 24‐hour disclosure to the State Securities Commission and stock exchange of a Board of Directors resolution approving an employee share issuance plan. It details an increase in charter capital through issuance of 2,000,000 new shares under an employee option program. This is not a full financial report, call transcript, or management change notice, but an announcement of a capital increase via new share issuance. Therefore it falls under Share Issue/Capital Change (SHA).
2023-03-07 Vietnamese
DCL: Thông báo ngày ĐKCC tổ chức ĐHĐCĐ thường niên năm 2023
Declaration of Voting Results & Voting Rights Announcements Classification · 80% confidence The document is a notice from the Ho Chi Minh City Stock Exchange announcing the ex‐rights date and record date for shareholders to participate and vote at the 2023 Annual General Meeting. It does not contain financial statements or dividend amounts, nor is it a call transcript or management change notice. It best fits the "Declaration of Voting Results & Voting Rights Announcements" category, which includes announcements of voting rights events such as record dates for shareholder meetings.
2023-03-01 Vietnamese
DCL: Thông báo thay đổi nhân sự - Phó Tổng giám đốc phụ trách tài chính
Board/Management Information Classification · 95% confidence The document is an official notification to the stock exchange of a change in personnel, specifically the appointment of a new Deputy CEO (finance) and the dismissal of the former CFO. It includes Board resolutions and formal announcements of senior management changes. This clearly falls under Board/Management Information.
2023-03-01 Vietnamese
DCL: Nghị quyết HĐQT về triệu tập ĐHĐCĐ thường niên năm 2023
Regulatory Filings Classification · 85% confidence The document is a regulatory disclosure filed to the State Securities Commission and Ho Chi Minh Stock Exchange announcing the Board of Directors’ resolution (Nghị quyết HĐQT) to convene the 2023 Annual General Meeting of shareholders, including date, registration deadline, format, and agenda. It is not the annual report itself, nor a proxy statement pack (no detailed solicitation materials are provided), nor minutes or presentations from the AGM. It is essentially a general regulatory announcement of the Board resolution, so it fits the fallback Regulatory Filings category (RNS).
2023-02-27 Vietnamese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.